Quest Diagnostics is expected to unveil its second-quarter results later this month, and analysts expect a single-digit ...

While Quest Diagnostics has outshined the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks ...

Company News Published 06/13/2025, 10:09 AM 0 Quest Diagnostics stock hits all-time high of $180.11 DGX 0.18% ...

Company News Published06/13/2025, 10:09 AM Quest Diagnostics stock hits all-time high of $180.11 View all comments (0)0 DGX 0.65% ...

Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services with a market capitalization of nearly $20 billion, has reached an all-time high, with its stock price soaring ...

BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and ...

Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and ...

Quest Diagnostics has an analyst consensus of Moderate Buy, with a price target consensus of $189.31, a 5.23% upside from current levels.

Robert W. Baird analyst Eric Coldwell maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $797.00. The company’s shares opened today at ...